A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies.
暂无分享,去创建一个
A. Tolcher | C. Takimoto | L. Denis | A. Patnaik | E. Rowinsky | L. Ochoa | L. Hammond | G. Schwartz | J. McGuire | A. Goetz | Bahram Forouzesh | J. Rizzo | J. Kwiatek